Functional modulation of the glucocorticoid receptor and suppression of NF-kappaB-dependent transcription by ursodeoxycholic acid.
about
Suppression of NF-kappaB-dependent gene expression by a hexamethylene bisacetamide-inducible protein HEXIM1 in human vascular smooth muscle cellsBile acids: regulation of apoptosis by ursodeoxycholic acidA large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis CA dose-up of ursodeoxycholic acid decreases transaminases in hepatitis C patientsGlucocorticoid-independent modulation of GR activity: Implications for immunotherapyClinical application of transcriptional activators of bile salt transporters.Excessive collagen accumulation in dystrophic (mdx) respiratory musculature is independent of enhanced activation of the NF-kappaB pathway.The influence of passive stretch and NF-κB inhibitors on the morphology of dystrophic muscle fibers.Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ductsUrsodeoxycholic Acid Ameliorates Apoptotic Cascade in the Rotenone Model of Parkinson's Disease: Modulation of Mitochondrial Perturbations.Suppression of the HPA axis during extrahepatic biliary obstruction induces cholangiocyte proliferation in the rat.Advances in pharmacotherapy for primary biliary cirrhosis.Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode.Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cellsSuppression of the HPA Axis During Cholestasis Can Be Attributed to Hypothalamic Bile Acid Signaling.Nuclear receptors as drug targets in cholestatic liver diseases.Nuclear receptors as therapeutic targets in cholestatic liver diseases.5β-Reduced steroids and human Δ(4)-3-ketosteroid 5β-reductase (AKR1D1).Role of nuclear receptors in the biliary epithelium.Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications.On the trail of the glucocorticoid receptor: into the nucleus and back.Management of cholestatic disease in 2017.Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells.UDCA slows down intestinal cell proliferation by inducing high and sustained ERK phosphorylation.Hydrophobic bile acid-induced micronuclei formation, mitotic perturbations, and decreases in spindle checkpoint proteins: relevance to genomic instability in colon carcinogenesis.Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth.S100A12 expression in patients with primary biliary cirrhosis.The effect of specific IKKβ inhibitors on the cytosolic expression of IκB-α and the nuclear expression of p65 in dystrophic (MDX) muscleReduced resting potentials in dystrophic (mdx) muscle fibers are secondary to NF-κB-dependent negative modulation of ouabain sensitive Na+-K+ pump activityNovel strategies and therapeutic options for the management of primary biliary cholangitis.Bile acids modulate the Golgi membrane fission process via a protein kinase Ceta and protein kinase D-dependent pathway in colonic epithelial cells.Chenodeoxycholic acid and deoxycholic acid inhibit 11 beta-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor.Effect of ursodeoxycholic acid on the pharmacokinetics of midazolam and CYP3A in the liver and intestine of rats.Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice.Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System.Ursodeoxycholic acid suppresses eosinophilic airway inflammation by inhibiting the function of dendritic cells through the nuclear farnesoid X receptor.Selective modulation of glucocorticoid receptor function toward development of novel anti-inflammation: lessons from a phenyl-pyrazolo-steroid cortivazol.In vivo treatment with the NF-κB inhibitor ursodeoxycholic acid (UDCA) improves tension development in the isolated mdx costal diaphragm.Chemoprevention of esophageal adenocarcinoma in a rat model by ursodeoxycholic acidFunction of nuclear steroid receptors in apoptosis: role of ursodeoxycholic acid
P2860
Q24294541-A7E51C17-96C9-4273-9446-821C57137EEAQ24653969-6433D477-A22E-4712-B562-ACF23201B75FQ27482028-2293E12A-A161-4E79-A53B-F369D01FBFC1Q27488742-A057984F-A6E1-420E-B514-07014AF5B5A7Q28077040-FB7B351F-FC47-42FE-B7C1-B50F713B90F2Q33709930-D93C2027-31D0-4BE1-B4A1-D52D7063D394Q33912578-DC522E22-10EB-4C34-9782-D1969F0B2BDFQ34792816-548D8845-9134-46FA-B2B4-CA72C875C763Q35087918-CE5159F4-DFC4-49F8-9892-66E44DD153FEQ35515556-8907B86A-7F1D-489E-8449-413EDC200D11Q35939397-32FE67C3-6423-43BD-B56C-8B071FFDF2BCQ36116022-F39A8139-5640-4C3E-8BA0-DD16BCFB0249Q36197335-2E0D84A5-7BE3-402D-B2A5-55029F80E1E3Q36330872-7CE041D5-BC25-439A-B282-0D1C08A84E58Q36331780-DE6AED18-F11B-4AF9-BA79-7C8113B238A8Q36786270-84FFCEA7-39D6-4C3D-9A10-844D0883B1C7Q37230857-9DCABE03-281A-4970-B6CC-98A24A961498Q37677101-F3C02917-6E29-4313-8C95-17EBD4B39E1FQ37892283-E875AAF8-FCB5-429C-9555-162D0FE336D1Q37919924-D6F47B27-CB79-4AD4-8D3F-EA8AEF6DC03EQ37939423-4703B4BA-DA6A-4D97-A40E-34031CC0704FQ38774857-04077150-9ABF-460B-9C86-DDD8C91D6ED7Q39170726-99E3261B-0542-4C75-85A7-59C2C3316691Q39497268-31E01A04-5725-4CC8-969F-A632308C622AQ39675362-35001275-96E0-4722-8930-2C931EBCEF17Q41017557-5C009B03-EBBE-4F6E-8166-5A59A552B9E1Q41702160-008B0FA9-52BB-4C51-B573-17D19EA4096AQ41888348-DD761D7E-2C19-4943-8528-95D8141E5D63Q42106765-240AC9F0-1C93-4215-A3C9-DB7F6FC0856CQ42375647-CDC8E2A5-7EC6-49DF-9C84-84D2AF7F9582Q43186622-5464A2C8-57DB-4425-9E36-47D85177D21BQ43996671-4894E181-A234-42AC-98B7-6C7CC1A910B0Q46102612-11FFEC2C-98A9-4CD4-B162-90CBB8DF75F5Q46440176-4A471B55-BB77-4125-ABE2-02FDA0B06EA6Q47135121-33F0A02E-9800-4571-9E27-D5C74EA88188Q49153341-C60098D1-0324-4A19-8468-D2FECF1CCC49Q50917134-166180B0-842C-4753-AA68-96A845CE931EQ53438484-59851207-FFF3-4E40-A42D-F9F86683913BQ57143240-AD09288A-D489-4E1F-B70A-E2FACFD1C5E0Q57760186-BA3DBB1E-8A8A-4BEA-BEB7-82A654E7490D
P2860
Functional modulation of the glucocorticoid receptor and suppression of NF-kappaB-dependent transcription by ursodeoxycholic acid.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Functional modulation of the g ...... ption by ursodeoxycholic acid.
@en
Functional modulation of the g ...... ption by ursodeoxycholic acid.
@nl
type
label
Functional modulation of the g ...... ption by ursodeoxycholic acid.
@en
Functional modulation of the g ...... ption by ursodeoxycholic acid.
@nl
prefLabel
Functional modulation of the g ...... ption by ursodeoxycholic acid.
@en
Functional modulation of the g ...... ption by ursodeoxycholic acid.
@nl
P2093
P2860
P356
P1476
Functional modulation of the g ...... ption by ursodeoxycholic acid.
@en
P2093
Morimoto C
Nakamura T
Yoshikawa N
P2860
P304
47371-47378
P356
10.1074/JBC.M107098200
P407
P577
2001-09-27T00:00:00Z